Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shweta Mandrekar"'
Publikováno v:
ASN Neuro, Vol 5 (2013)
Traumatic injury or disease of the spinal cord and brain elicits multiple cellular and biochemical reactions that together cause or are associated with neuropathology. Specifically, injury or disease elicits acute infiltration and activation of immun
Externí odkaz:
https://doaj.org/article/c5230484558546c09727ee7f6e76ee5a
Autor:
Zhen Guan, Andrew D. Gaudet, Xiaokui Mo, David R Sweet, Shweta Mandrekar-Colucci, Phillip G. Popovich, Philipp J Schmitt, Jodie C. E. Hall, Xinyang Xu, Mireia Guerau-de-Arellano
Publikováno v:
Journal of Neuroscience. 36:8516-8532
Axon regeneration after spinal cord injury (SCI) fails due to neuron-intrinsic mechanisms and extracellular barriers including inflammation. microRNA (miR)-155–5p is a small, noncoding RNA that negatively regulates mRNA translation. In macrophages,
Autor:
Yi Zhang, Todd Shawler, Alexander G. Rabchevsky, Nicole D. Powell, Caroline C. Whitacre, Mark S. Nash, Jonathan Wells, Anna Bratasz, Brenda F. Reader, Shweta Mandrekar-Colucci, John F. Sheridan, Zachary M. Weil, Zhen Guan, Kun Huang, Phillip G. Popovich
Publikováno v:
Journal of Neuroscience. 33:12970-12981
Autonomic dysreflexia (AD), a potentially dangerous complication of high-level spinal cord injury (SCI) characterized by exaggerated activation of spinal autonomic (sympathetic) reflexes, can cause pulmonary embolism, stroke, and, in severe cases, de
Publikováno v:
Journal of Neuroscience. 32:10117-10128
Alzheimer's disease is associated with a disruption of amyloid β (Aβ) homeostasis, resulting in the accumulation and subsequent deposition of Aβ peptides within the brain. The peroxisome proliferator-activated receptor-γ (PPARγ) is a ligand-acti
Publikováno v:
Expert Opinion on Therapeutic Targets. 15:1085-1097
Alzheimer's disease (AD) is characterized by the accumulation and extensive deposition of amyloid β (Aβ) in the parenchyma of the brain. This accumulation of amyloid is associated with perturbations in synaptic function, impairments in energy metab
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 9:156-167
One hundred and fifty years have elapsed since the original discovery of the microglial cell by Virchow. While this cell type has been well studied, the role of microglia in the pathology of many central nervous system diseases still remains enigmati
Publikováno v:
Neurotherapeutics. 5:481-489
Alzheimer's disease (AD) is characterized by the deposition of beta-amyloid within the brain parenchyma and is accompanied by the impairment of neuronal metabolism and function, leading to extensive neuronal loss. The disease involves the perturbatio
Autor:
Noam Zelcer, Timothy M. Willson, C. Y. Daniel Lee, Jill C. Richardson, Shweta Mandrekar, David M. Holtzman, Jon L. Collins, Jonathan D. Smith, Qingguang Jiang, Gary E. Landreth, David Riddell, Paige E. Cramer, Karen Mann, Peter Tontonoz, Brandy L. Wilkinson, Bruce T. Lamb, Thomas A. Comery
Publikováno v:
Neuron, 58(5), 681-693. Cell Press
Apolipoprotein E is associated with age-related risk for Alzheimer’s disease and plays critical roles in Aβ homeostasis. We report that ApoE plays a previously unappreciated role in facilitating the proteolytic clearance of soluble Aβ from the br
Publikováno v:
ASN NEURO
ASN Neuro, Vol 5 (2013)
ASN Neuro, Vol 5 (2013)
Traumatic injury or disease of the spinal cord and brain elicits multiple cellular and biochemical reactions that together cause or are associated with neuropathology. Specifically, injury or disease elicits acute infiltration and activation of immun
Autor:
David M. Holtzman, Qingguang Jiang, Jessica Koenigsknecht-Talboo, Shweta Mandrekar, Gary E. Landreth, C. Y. Daniel Lee
Alzheimer's disease is characterized by the progressive deposition of β-amyloid (Aβ) within the brain parenchyma and its subsequent accumulation into senile plaques. Pathogenesis of the disease is associated with perturbations in Aβ homeostasis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f94216e611ce06dc01d3a7380acf8e0c
https://europepmc.org/articles/PMC3034143/
https://europepmc.org/articles/PMC3034143/